Report cover image

HLA Typing for Transplant Market by Technology (Molecular Assay Technologies, Non-Molecular Assay Technologies), Product & Service (Instruments, Reagents & Consumables, Software & Services), Application, End-User - Global Forecast 2023-2030

Publisher 360iResearch
Published Oct 04, 2023
Length 180 Pages
SKU # IRE18317608

Description

HLA Typing for Transplant Market by Technology (Molecular Assay Technologies, Non-Molecular Assay Technologies), Product & Service (Instruments, Reagents & Consumables, Software & Services), Application, End-User - Global Forecast 2023-2030


The HLA Typing for Transplant Market size was estimated at USD 698.78 million in 2022 and expected to reach USD 735.56 million in 2023, at a CAGR 6.24% to reach USD 1,134.62 million by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the HLA Typing for Transplant Market.
  • Based on Technology, market is studied across Molecular Assay Technologies and Non-Molecular Assay Technologies. The Molecular Assay Technologies is further studied across PCR-Based Molecular Assays and Sequencing-Based Molecular Assays. The PCR-Based Molecular Assays is further studied across Real-Time PCR, Sequence-Specific Oligonucleotide-PCR, and Sequence-Specific Primer-PCR. The Sequence-Specific Oligonucleotide-PCR is further studied across Next-Generation Sequencing and Sanger Sequencing. The Non-Molecular Assay Technologies is projected to witness significant market share during forecast period.
  • Based on Product & Service, market is studied across Instruments, Reagents & Consumables, and Software & Services. The Reagents & Consumables is projected to witness significant market share during forecast period.
  • Based on Application, market is studied across Diagnostic Applications and Research Applications. The Diagnostic Applications is further studied across Antibody Screening and Chimerism Monitoring. The Research Applications is projected to witness significant market share during forecast period.
  • Based on End-User, market is studied across Hospitals & Transplant Centers, Independent Reference Laboratories, and Research Laboratories & Academic Institutes. The Independent Reference Laboratories is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the HLA Typing for Transplant Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape HLA Typing for Transplant Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the HLA Typing for Transplant Market, highlighting leading vendors and their innovative profiles. These include Affymetrix, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., CareDx, Inc., F. Hoffman-La Roche Ltd., Fujirebio, Inc., Genome Diagnostics B.V., Hologic, Inc., Illumina, Inc., Immucor, Inc., Luminex Corporation, Omixon Inc., QIAGEN N.V., Takara Bio Inc., TBG Diagnostics Ltd., and Thermo Fisher Scientific, Inc..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the HLA Typing for Transplant Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the HLA Typing for Transplant Market?
  3. What is the competitive strategic window for identifying opportunities in the HLA Typing for Transplant Market?
  4. What are the latest technology trends and regulatory frameworks in the HLA Typing for Transplant Market?
  5. What is the market share of the leading vendors in the HLA Typing for Transplant Market?
  6. Which modes and strategic moves are suitable for entering the HLA Typing for Transplant Market?


Note: PDF & Excel + Online Access - 1 Year

Table of Contents

180 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. HLA Typing for Transplant Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing public-private funding for target research activities
5.1.1.2. Increasing number of solid organ transplants and expanding geriatric population
5.1.1.3. Rising prevalence of infectious diseases and soaring number of bone marrow and blood transplant processes
5.1.2. Restraints
5.1.2.1. High cost of HLA typing procedures
5.1.3. Opportunities
5.1.3.1. Progressive developments of PCR-based HLA-typing methods
5.1.3.2. Technological advancements in the field of transplant diagnostics
5.1.4. Challenges
5.1.4.1. Concerns regarding inaccuracy of HLA typing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. HLA Typing for Transplant Market, by Technology
6.1. Introduction
6.2. Molecular Assay Technologies
6.3.1. PCR-Based Molecular Assays
6.3.2.1. Real-Time PCR
6.3.2.2. Sequence-Specific Oligonucleotide-PCR
6.3.2.3.1. Next-Generation Sequencing
6.3.2.3.2. Sanger Sequencing
6.3.2.3. Sequence-Specific Primer-PCR
6.3.2. Sequencing-Based Molecular Assays
6.3. Non-Molecular Assay Technologies
7. HLA Typing for Transplant Market, by Product & Service
7.1. Introduction
7.2. Instruments
7.3. Reagents & Consumables
7.4. Software & Services
8. HLA Typing for Transplant Market, by Application
8.1. Introduction
8.2. Diagnostic Applications
8.3.1. Antibody Screening
8.3.2. Chimerism Monitoring
8.3. Research Applications
9. HLA Typing for Transplant Market, by End-User
9.1. Introduction
9.2. Hospitals & Transplant Centers
9.3. Independent Reference Laboratories
9.4. Research Laboratories & Academic Institutes
10. Americas HLA Typing for Transplant Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific HLA Typing for Transplant Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa HLA Typing for Transplant Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Affymetrix, Inc.
14.1.2. Becton, Dickinson, and Company
14.1.3. Bio-Rad Laboratories, Inc.
14.1.4. CareDx, Inc.
14.1.5. F. Hoffman-La Roche Ltd.
14.1.6. Fujirebio, Inc.
14.1.7. Genome Diagnostics B.V.
14.1.8. Hologic, Inc.
14.1.9. Illumina, Inc.
14.1.10. Immucor, Inc.
14.1.11. Luminex Corporation
14.1.12. Omixon Inc.
14.1.13. QIAGEN N.V.
14.1.14. Takara Bio Inc.
14.1.15. TBG Diagnostics Ltd.
14.1.16. Thermo Fisher Scientific, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us